Non-linear relationship between serum cholesterol levels and cognitive change among older people in the preclinical and prodromal stages of dementia: a retrospective longitudinal study in Taiwan
- PMID: 38816835
- PMCID: PMC11138028
- DOI: 10.1186/s12877-024-05030-0
Non-linear relationship between serum cholesterol levels and cognitive change among older people in the preclinical and prodromal stages of dementia: a retrospective longitudinal study in Taiwan
Abstract
Background: Adverse effects of rigorously lowering low-density lipoprotein cholesterol on cognition have been reported; therefore, we aimed to study the contribution of serum cholesterol in cognitive decline in older people with or without dementia.
Methods: Cognitive function was assessed by the Cognitive Abilities Screening Instrument (CASI). We investigated associations between serum cholesterol with cognitive decline using multiple regressions controlling for the effects of demographics, vascular risk factors, and treatments.
Results: Most associations between cholesterol and CASI scores could be explained by non-linear and inverted U-shaped relationships (R2 = 0.003-0.006, p < 0.016, Šidákcorrection). The relationships were most evident between changes in cholesterol and CASI scores in older people at the preclinical or prodromal stages of dementia (R2 = 0.02-0.064, p values < 0.016). There were no differences in level of changes in CASI scores between individuals in 1st decile and 10th decile groups of changes in cholesterol (p = 0.266-0.972). However, individuals in the 1st decile of triglyceride changes and with stable and normal cognitive functions showed significant improvement in CASI scores compared to those in the 10th decile (t(202) = 2.275, p values < 0.05).
Conclusion: These findings could implicate that rigorously lowering cholesterol may not be suitable for the prevention of cognitive decline among older people, especially among individuals in preclinical or prodromal stages of dementia.
Keywords: Cholesterol; Cognitive function; Dementia; Mild cognitive impairment; Subjective cognitive decline.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study.J Am Geriatr Soc. 2017 Dec;65(12):2627-2633. doi: 10.1111/jgs.15077. Epub 2017 Sep 21. J Am Geriatr Soc. 2017. PMID: 28940184 Free PMC article.
-
Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses.J Nutr Health Aging. 2012 Jul;16(7):631-5. doi: 10.1007/s12603-011-0341-9. J Nutr Health Aging. 2012. PMID: 22836705
-
Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study.Mol Neurodegener. 2019 Dec 30;14(1):51. doi: 10.1186/s13024-019-0353-1. Mol Neurodegener. 2019. PMID: 31888696 Free PMC article.
-
Neuropsychiatric symptoms in the prodromal stages of dementia.Curr Opin Psychiatry. 2014 May;27(3):230-5. doi: 10.1097/YCO.0000000000000050. Curr Opin Psychiatry. 2014. PMID: 24613979 Review.
-
Blood-based biomarkers in hypothalamic-pituitary axes for the risk of dementia or cognitive decline: a systematic review and meta-analysis.Aging (Albany NY). 2020 Oct 26;12(20):20350-20365. doi: 10.18632/aging.103813. Epub 2020 Oct 26. Aging (Albany NY). 2020. PMID: 33104518 Free PMC article.
Cited by
-
Lipid trajectories improve risk models for Alzheimer's disease and mild cognitive impairment.J Lipid Res. 2025 Jan;66(1):100714. doi: 10.1016/j.jlr.2024.100714. Epub 2024 Nov 23. J Lipid Res. 2025. PMID: 39586400 Free PMC article.
-
Dyslipidemia and cerebral atrophy among health check-up individuals: A cross-sectional study.Int J Cardiol Cardiovasc Risk Prev. 2025 Mar 8;25:200394. doi: 10.1016/j.ijcrp.2025.200394. eCollection 2025 Jun. Int J Cardiol Cardiovasc Risk Prev. 2025. PMID: 40160696 Free PMC article.
-
Association between hyperlipidemia and postoperative delirium risk: a systematic review and meta-analysis.Front Aging Neurosci. 2025 Mar 18;17:1544838. doi: 10.3389/fnagi.2025.1544838. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40171385 Free PMC article.
-
Lipid Trajectories Improve Risk Models for Alzheimer's Disease and Mild Cognitive Impairment.medRxiv [Preprint]. 2024 Sep 28:2024.09.27.24314494. doi: 10.1101/2024.09.27.24314494. medRxiv. 2024. Update in: J Lipid Res. 2025 Jan;66(1):100714. doi: 10.1016/j.jlr.2024.100714. PMID: 39399044 Free PMC article. Updated. Preprint.
-
Association between platelet-to-high-density lipoprotein cholesterol ratio and cognitive function in older americans: insights from a cross-sectional study.Sci Rep. 2024 Oct 28;14(1):25769. doi: 10.1038/s41598-024-77813-9. Sci Rep. 2024. PMID: 39468327 Free PMC article.
References
-
- Ranson JM, Rittman T, Hayat S, Brayne C, Jessen F, Blennow K, van Duijn C, Barkhof F, Tang E, Mummery CJ, et al. Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health services—part 2 of 6. Alzheimer’s Res Ther. 2021;13(1):169. doi: 10.1186/s13195-021-00895-4. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical